DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Haynes R, Baigent C, Harden P. et al.
Campath, calcineurin inhibitor reduction and chronic allograft nephropathy (3C) study: background, rationale, and study protocol.
Transplantation Research 2013;
2: 7
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.